Nearly US$16bn (€13.3bn) of life sciences real estate changed hands last week. In a world where medical research companies around the world are racing to develop COVID-19 vaccines and treatments, it looks to be a sign of the times. Life sciences real estate – think laboratories and specialised office space – was a growing sub-sector before this year, but the coronavirus pandemic has further boosted the trend.

Read more: https://bit.ly/2IGubw8